Proton's device aims to help those with kidney disease, and cut heart failure risks | TechCrunch

Ranamukhaarachchi told TechCrunch the team did over 100 in-depth interviews with care teams to research their product: "These highlighted the devastating consequences of 'flying blind' when managing potassium levels, because delays in monitoring can lead to severe, even life-threatening, situations for patients, especially those with chronic kidney disease or heart failure."

Read at TechCrunch